These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 601749)

  • 41. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bovine antithrombin-III: miscellaneous observations.
    Seegers WH; Novoa E; Andary TJ; Hassouna HI
    Thromb Res; 1977 Dec; 11(6):809-15. PubMed ID: 601751
    [No Abstract]   [Full Text] [Related]  

  • 43. Isoform composition of antithrombin in a covalent antithrombin-heparin complex.
    Chan AK; Berry LR; Paredes N; Parmar N
    Biochem Biophys Res Commun; 2003 Oct; 309(4):986-91. PubMed ID: 13679071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of heparin-like antithrombotics having perphosphorylated thrombin binding domains.
    Buijsman RC; Basten JE; Dreef-Tromp CM; van der Marel GA; van Boeckel CA; van Boom JH
    Bioorg Med Chem; 1999 Sep; 7(9):1881-90. PubMed ID: 10530936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
    Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
    Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet antithrombins: role of thrombin binding and the release of platelet fibrinogen.
    Watanabe K; Chao FC; Tullis JL
    Br J Haematol; 1977 Jan; 35(1):123-33. PubMed ID: 869991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RNA aptamer to thrombin binds anion-binding exosite-2 and alters protease inhibition by heparin-binding serpins.
    Jeter ML; Ly LV; Fortenberry YM; Whinna HC; White RR; Rusconi CP; Sullenger BA; Church FC
    FEBS Lett; 2004 Jun; 568(1-3):10-4. PubMed ID: 15196911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of heparin in vitro and in vivo to plasma proteins.
    Marciniak E
    J Lab Clin Med; 1974 Sep; 84(3):344-56. PubMed ID: 4368450
    [No Abstract]   [Full Text] [Related]  

  • 49. A simple 2-step isolation procedure for human antithrombin II/III and its biological activity after insolubilization to agarose.
    Thaler E; Schmer G
    Trans Am Soc Artif Intern Organs; 1974; 20 B():516-20. PubMed ID: 4450303
    [No Abstract]   [Full Text] [Related]  

  • 50. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation on interaction of fractionated 3H-heparin with plasma proteins by gel filtration chromatography.
    Watanabe J; Nakagaki H; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Jul; 12(7):416-22. PubMed ID: 2480440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Most clot-bound thrombin activity is inhibited by plasma antithrombin during clot aging, but a very small fraction survives.
    Komatsu Y; Hayashi H
    Biol Pharm Bull; 2000 Apr; 23(4):502-5. PubMed ID: 10784436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A method to determine the affinity of heparin to thrombin and antithrombin III on equilibrium gel permeation chromatography.
    Oshima G; Uchiyama H; Nagasawa K
    J Biochem; 1984 Oct; 96(4):1033-9. PubMed ID: 6520110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.
    Wunderwald P; Schrenk WJ; Port H
    Thromb Res; 1982 Feb; 25(3):177-91. PubMed ID: 6175043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of heparin on factor XIa and plasmin.
    Rosenberg RD
    Thromb Diath Haemorrh; 1975 Feb; 33(1):51-62. PubMed ID: 235160
    [No Abstract]   [Full Text] [Related]  

  • 56. Reactivities of the S2 and S3 subsite residues of thrombin with the native and heparin-induced conformers of antithrombin.
    Rezaie AR
    Protein Sci; 1998 Feb; 7(2):349-57. PubMed ID: 9521111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
    Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI
    Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation.
    Ruzicka K; Wojta J; Artemiou O; Birsan T; Quehenberger P; Kapiotis S; Hofbauer R; Speiser W
    Life Sci; 1998; 63(17):1493-503. PubMed ID: 9808060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the molecular mass dependency of heparin stimulation of heparin cofactor II:thrombin interaction to antithrombin III:thrombin interaction.
    Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1987 May; 46(3):491-502. PubMed ID: 3603437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.